119 related articles for article (PubMed ID: 36436288)
1. Factors Associated With Cosmetic Outcomes After Treatment With a Novel Form of Breast Intraoperative Radiation Therapy.
Squeo GC; Meneveau MO; Varhegyi NE; Lattimore CM; Janowski E; Showalter TN; Showalter SL
J Surg Res; 2023 Mar; 283():514-522. PubMed ID: 36436288
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
4. A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial.
Showalter SL; Petroni G; Trifiletti DM; Libby B; Schroen AT; Brenin DR; Dalal P; Smolkin M; Reardon KA; Showalter TN
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):46-54. PubMed ID: 27511846
[TBL] [Abstract][Full Text] [Related]
5. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
6. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
Trombetta M; Hall M; Julian TB
Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
[TBL] [Abstract][Full Text] [Related]
7. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
[TBL] [Abstract][Full Text] [Related]
8. Implementation of an HDR brachytherapy-based breast IORT program: Initial experiences.
Dutta SW; Mehaffey JH; Sanders JC; Meneveau MO; Lattimore C; Libby B; Brenin DR; Schroen AT; Janowski EM; Lynch C; Lash DJ; Showalter TN; Showalter SL
Brachytherapy; 2019; 18(3):285-291. PubMed ID: 30846329
[TBL] [Abstract][Full Text] [Related]
9. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
10. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up.
Dragun AE; Harper JL; Jenrette JM; Sinha D; Cole DJ
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):354-8. PubMed ID: 17383829
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing cosmetic results after conservation therapy for breast cancer.
Taylor ME; Perez CA; Halverson KJ; Kuske RR; Philpott GW; Garcia DM; Mortimer JE; Myerson RJ; Radford D; Rush C
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):753-64. PubMed ID: 7860386
[TBL] [Abstract][Full Text] [Related]
14. Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy.
Hassinger TE; Showalter TN; Schroen AT; Brenin DR; Berger AC; Libby B; Showalter SL
J Med Imaging Radiat Oncol; 2018 Dec; 62(6):835-840. PubMed ID: 30102019
[TBL] [Abstract][Full Text] [Related]
15. Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study.
Garsa AA; Ferraro DJ; DeWees T; Margenthaler JA; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Zoberi I
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):965-70. PubMed ID: 23058060
[TBL] [Abstract][Full Text] [Related]
16. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.
Stecklein SR; Shaitelman SF; Babiera GV; Bedrosian I; Black DM; Ballo MT; Arzu I; Strom EA; Reed VK; Dvorak T; Smith BD; Woodward WA; Hoffman KE; Schlembach PJ; Kirsner SM; Nelson CL; Yang J; Guerra W; Dibaj S; Bloom ES
Pract Radiat Oncol; 2019 Jan; 9(1):e4-e13. PubMed ID: 30125673
[TBL] [Abstract][Full Text] [Related]
17. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
Hepel JT; Leonard KL; Sha S; Graves TA; Wiggins DL; Mastras D; Pittier A; ; Wazer DE
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1143-1149. PubMed ID: 32721422
[TBL] [Abstract][Full Text] [Related]
19. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.
Arthur DW; Koo D; Zwicker RD; Tong S; Bear HD; Kaplan BJ; Kavanagh BD; Warwicke LA; Holdford D; Amir C; Archer KJ; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):681-9. PubMed ID: 12788173
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
